Portfolio Company Collaboration: ENABLE Biotech

As a small agile CDMO we are focused on being flexible to meet the unique needs of startup and spinout companies. Our available capacity and expertise can accelerate First-in-Human trials, offer competitive pricing, and access to patients in EU. Our team also brings the expertise required to assist with preparing CMC sections for regulatory submissions and to incorporate clinical requirements for scaling up manufacturing processes starting in early development stages. We are interested in meeting with early-stage CGT companies seeking process development and manufacturing services.